Withanolide D, carrying the baton of Indian Rasayana herb as a lead candidate of antileukemic agent in modern medicine

Advances in Experimental Medicine and Biology

Volumn 749, Issue , 2012, Pages 295-312

  Mondal, Susmita ^a,b   Roy, Saptarshi ^a   Maity, Rita ^a   Mallick, Asish ^a   Sangwan, Rajender ^c   Misra Bhattacharya, Shailja ^d   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Sammilani Mahavidyalaya ^*  (India)

^c CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; CERAMIDE; CURCUMIN; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 2; INTERLEUKIN 4; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE D;

ADAPTIVE IMMUNITY; AGING; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ANTILEUKEMIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOACCUMULATION; BONE MARROW SUPPRESSION; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PATIENT; CANCER RESISTANCE; CARBON NUCLEAR MAGNETIC RESONANCE; CD4+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DEATH; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONFERENCE PAPER; DNA FRAGMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVATION; HELPER CELL; HERB; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMORAL IMMUNITY; IC 50; IMMUNE RESPONSE; IMMUNOMODULATION; IN SITU HYBRIDIZATION; IN VITRO STUDY; INFRARED RADIATION; INNATE IMMUNITY; LEUKEMIA CELL; LYMPHOBLAST; LYMPHOCYTE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVENT EXTRACTION; STRESS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; CERAMIDES; HERBAL MEDICINE; HUMANS; LEUKEMIA; MEDICINE, AYURVEDIC; WITHANOLIDES;

WITHANIA SOMNIFERA;

EID: 84863736746     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3381-1_20     Document Type: Conference Paper

References (78)

1. Agarwal R, Diwanay S, Patki P, Patwardhan B (1999) Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune in flammation. J Ethnopharmacol 67:27-35
2. Bandyopadhyay M, Jha S, Tepfer D (2007) Changes in morphological phenotypes and withanolide composition of Ri-transformed roots of Withania somnifera. Plant Cell Rep 26:599-609
3. Bani S, Gautam M, Sheikh FA, Khan B, Satti NK, Suri KA, Qazi GN, Patwardhan B (2006) Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using fl ow cytometry. J Ethnopharmacol 107:107-15
4. Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75:547-55
5. Bhattacharya SK, Satyan KS, Ghosal S (1997) Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 35:236-239
6. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S (2000) Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 7:463-469
7. Bhattacharya K, Samanta SK, Tripathi R, Mallick A, Chandra S, Pal BC, Shaha C, Mandal C (2010) Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochem Pharmacol 79:361-72
8. Bourbon NA, Yun J, Kester M (2000) Ceramide directly activates protein kinase C to regulate a stress-activated protein kinase signaling complex. J Biol Chem 275:35617-35623
9. Bretsche PA, Ismail N, Menon JN, Power CA, Uzonna J, Wei G (2001) Vaccination against and treatment of tuberculosis, the leishmaniasis and AIDS: perspectives from basic immunology and immunity to chronic intracellular infections. Cell Mol Life Sci 58:1879-96
10. Chatterjee S (1999) Neutral sphingomyelinase: past, present and future. Chem Phys Lipids 102:79-96
11. Chaurasiya ND, Uniyal GC, Lal P, Misra L, Sangwan NS, Tuli R, Sangwan RS (2008) Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal 19:148-54
12. Chaurasiya ND, Sangwan RS, Misra LN, Tuli R, Sangwan NS (2009) Metabolic clustering of a core collection of Indian ginseng Withania somnifera Dunal through DNA, isoenzyme, polypeptide and withanolide pro file diversity. Fitoterapia 80:496-505
13. Chen LC, Lin FC, Chang TW, Huang CW, Teng FC, Lin SY (2008) Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111:4365-4374
14. Chowdhury K, Neogy RK (1975) Mode of action of withaferin A and withanolide D. Biochem Pharmacol 24:919-920
15. Chowdhury S, Bandyopadhyay S, Mandal C, Chandra S, Mandal C (2008) Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study. BMC Cancer 8:40
16. Clarke CJ, Snook CF, Tani M, Matmati N, Marchesini N, Hannun YA (2006) The extended family of neutral aphingomyelinase. Biochemistry 45:11247-11256
17. Das T, Sa G, Saha B, Das K (2010) Multifocal signal modulation therapy of cancer: ancient weapon, modern targets. Mol Cell Biochem 336:85-95
18. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
19. Davis L, Kuttan G (2000) Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193-200
20. Dhuley JN (2000) Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol 70:57-63
21. Diwanay S, Chitre D, Patwardhan B (2004) Immunoprotection by botanical drugs in cancer chemotherapy. J Ethnopharmacol 90:49-55
22. Dobrowsky RT, Hannun YA (1992) Ceramide stimulates a cytosolic protein phosphatase 2A. J Biol Chem 267:5048-5051
23. Frey AB, Monu N (2008) Signaling defects in anti-tumor T cells. Immunol Rev 222:192-205
24. Gamoh K, Hirayama M, Ikekawa N (1984) Stereocontrolled synthesis of withanolide D and related compounds. J Chem Soc Perkin Trans 1:449-454
25. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178-94
26. Ghosh S, Bandyopadhyay S, Pal S, Das B, Bhattacharya DK, Mandal C (2005) Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of over expressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukemia. Br J Hematol 128:35-41
27. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
28. Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 26:3125-3128
29. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859
30. Huang WC, Chen CL, Lin YS, Lin CF (2011) Apoptotic sphingolipid ceramide in cancer therapy. J Lipids 2011:565316
31. Jaffrezou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G (1996) Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 15:2417-2424
32. Jarvis WD, Fornari FA, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S (1997) Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 52:935-947
33. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG (2003) Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 74:125-132
34. Khan S, Malik F, Suri KA, Singh J (2009) Molecular insight into the immune up-regulatory properties of the leaf extract of ashwagandha and identification of Th1 immunostimulatory chemical entity. Vaccine 27:6080-7
35. Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223-246
36. Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961-71
37. Kurup VP, Barrios CS (2008) Immunomodulatory effects of curcumin in allergy. Mol Nutr Food Res 52:1031-9
38. Liscovitch M, Cantley LC (1994) Lipid second messengers. Cell 77:329-34
39. Malagarie CS, Segui B, Leveque S, Garcia V, Carpentier S, Altie MF, Brouchet A, Gouaze V, Andrieu AN, Barreira Y, Benoist H, Levade T (2004) Role of FAN in tumor necrosis factoralpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D galactosaminesensitized mice. J Biol Chem 279:18648-18655
40. Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN (2007) A standardized root extract of Withania somnifera and its major constituent withanolide- A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80:1525-38
41. Malik F, Kumar A, Bhushan S, Mondhe DM, Pal HC, Sharma R, Khajuria A, Singh S, Singh G, Saxena AK, Suri KA, Qazi GN, Singh J (2009) Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardized herbal formulation of Withania somnifera. Eur J Cancer 45:1494-509
42. Mandal C, Chatterjee M, Sinha D (2000) Investigation of 9-O-Acetylated sialoglycocongugates in childhood acute lymphoblastic leukaemia. Br J Hematol 110:801-812
43. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS, Mandal C (2008) Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13:1450-64
44. Mandal C, Tringali C, Mondal S, Anastasia L, Chandra S, Venerando B, Mandal C (2009) Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells. Int J Cancer 126:337-349
45. Mandal C, Schwartz-Albiez R, Vlasak R (2011) Functions and biosynthesis of O-acetylated sialic acids. In: Rita G-S, Philippe D, Mark von I (eds) A review "Topics in current chemistry", Vol: SialoGlyco Chemistry and Biology. Top Curr Chem. 2012 Feb 28 [Epub ahead of print].
46. Marchesini N, Luberto C, Hannun YA (2003) Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J Biol Chem 278:13775-13783
47. McAfee JG, MacVittie TJ (2001) The impact of recent advances in immunology and cancer therapy on nuclear medicine. Semin Nucl Med 31:342-9
48. Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R (2008) Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615:47-79
49. Michael JM, Lavin MF, Watters DJ (1997) Resistance to radiation induced apoptosis in Burkitts lymphoma cells is associated with defective ceramide signaling. Cancer Res 57:3600-3605
50. Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, Tuli R (2008) Withanolides from Withania somnifera roots. Phytochemistry 69:1000-1004
51. Mondal S, Chandra S, Mandal C (2010a) Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia. Leuk Res 34:463-470
52. Mondal S, Mandal C, Sangwan R, Chandra S, Mandal C (2010b) Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Mol Cancer 9:239
53. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: Promising resources for cancer drug discovery. Anti Cancer Agents Med Chem 12(1):49-75
54. Mukherjee K, Chowdhury S, Mondal S, Mandal C, Chandra S, Bhadra RK, Mandal C (2007) 9-O-acetylated GD3 triggers programmed cell death in mature erythrocytes. Biochem Biophys Res Commun 362:651-657
55. Muralikrishnan G, Dinda AK, Shakeel F (2010) Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Invest 39: 688-98
56. Pal S, Ghosh S, Bandyopadhyay S, Mandal CN, Bandhyopadhyay S, Bhattacharya DK, Mandal C (2004a) Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukaemia. Int J Cancer 111:270-277
57. Pal S, Ghosh S, Mandal CN, Kohla G, Brossmer R, Isecke R, Merling A, Schauer R, Schwartz- Albiez R, Bhattacharya DK, Mandal C (2004b) Purification and characterization of 9-O-acetylated sialoglycoproteins from leukaemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukaemia. Glycobiology 14:859-870
58. Perry DK (2000) The role of de novo ceramide synthesis in chemotherapy-induced apoptosis. Ann NY Acad Sci 905:91-96
59. Pui CH, Robison LL, Look AT (2008) Acute lymphoblastic leukaemia. Lancet 371:1030-43
60. Roja G, Heble MR, Sipahimalani AT (1991) Tissue cultures of Withania somnifera: morphogenesis and withanolide synthesis. Phytother Res 5:185-187
61. Saddoughi SA, Song P, Ogretmen B (2008) Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49:413-40
62. Sanchez AM, Cazenave SM, Olea N, Vara D, Chiloeches A, Laviada I (2007) Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase and JNK activation. Apoptosis 12:2013-2024
63. Sawada M, Nakashima S, Banno Y, Yamakawa H, Hayashi K, Takenaka K, Nishimura Y, Sakai N, Nozawa Y (2000) Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide induced apoptosis in C6 glioma cells. Cell Death Differ 7:761-772
64. Schimmer AD (2008) Apoptosis in leukemia: from molecular pathways to targeted therapies. Best Pract Res Clin Haematol 21:5-11
65. Senchenkov A, Litvak DA, Cabot MC (2001) Targeting ceramide metabolism-a strategy for overcoming drug resistance. J Natl Cancer Inst 93:347-357
66. Shurin MR, Kalinski R (1999) Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 21:339-359
67. Singh RH, Narsimhamurthy K, Singh G (2008) Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 9:369-374
68. Sinha D, Bhattacharya DK, Mandal C (1999a) Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe. Leukemia 13:119-125
69. Sinha D, Bhattacharya DK, Mandal C (1999b) Novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia 13:309-312
70. Smyth ML, Obeid LM, Hannun YA (1997) Ceramide: a novel lipid mediator of apoptosis. Adv Pharmacol 41:133-154
71. Sobue S, Iwasaki T, Sugisaki C, Nagata K, Kikuchi R, Murakami M, Takagi A, Kojima T, Banno Y, Akao Y, Nozawa Y, Kannagi R, Suzuki M, Abe A, Naoe T, Murate T (2006) Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 20:2042-6
72. Sonnino S, Aureli M, Loberto N, Chigorno V, Prinetti A (2010) Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases. FEBS Lett 584:1914-22
73. Tan TT, White E (2008) Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. Adv Exp Med Biol 615:81-104
74. Tuli R, Sangwan RS (eds) (2009) Ashwagandha (Withania somnifera): a model Indian medicinal plant. Council of Scientific and Industrial Research, 1st edn. Army Printing Press, Lucknow.
75. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79
76. Wyllie AH (1980) Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-6
77. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinase on apoptosis. Science 270:1326-1331
78. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B (1996) Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 50:69-76